March 30, 2023
MatTek and Visikol Announce Commercial Integration
MatTek CEO Alex Armento and Visikol CEO Dr. Michael Johnson, announced a commercial integration under the MatTek name.
News
February 22, 2023
MatTek Launches New Lab Grown Human Nasal Tissue
MatTek Life Sciences announced the launch of their newest lab-grown, three-dimensional human tissue, EpiNasal.
January 18, 2023
MatTek Delivers First Annual University Course
MatTek has taken the next step in its education program by delivering a curriculum in the Master of Biotechnology at the prestigious Sorbonne University in Paris, France. The world’s leading producer of 3D human reconstructed tissues as an alternative to animal testing, MatTek has a long commitment to share its expertise and to educate the next generation of scientists about this technology.
September 13, 2022
MatTek and World Precision Instruments Jointly Announce New Distribution Agreement
MatTek and WPI announced today distribution agreement allowing customers to purchase PermaCell Plates and STX HTS EVOM™ Electrode together.
March 25, 2022
MatTek Announces Production and Shipping of EpiOral Tissues from European Facility to Better Service the Wider Market
MatTek Life Sciences will produce and distribute EpiOral from its production facility in Slovakia, continuing the BICO groups’ focus on providing on-demand tissues to the European market. MatTek Life Sciences, a Boston-area tissue engineering company and a part of... Read More
